Covid-19 – Day 971: Novavax Recombinant Protein Vaccine
(E) The FDA has just approved the Novavax vaccine, which is now the four Covid-19 vaccine in the U.S after Pfizer, Moderna, and J&J. Novavax’s vaccine leverages a recombinant protein […]
(E) The FDA has just approved the Novavax vaccine, which is now the four Covid-19 vaccine in the U.S after Pfizer, Moderna, and J&J. Novavax’s vaccine leverages a recombinant protein […]
(E) Covid-19 has certainly pushed to the edge, research on the immune system, and in particular the role of the T cells. Two recent article from the Harvard Medical School […]
(E) The LKS Faculty of Medicine at the University of Hong Kong found in a new research study why Omicron is less dangerous than Delta but more viral than Delta. […]
(E) What do we know about the SARS-Cov-2 variant named Omicron? From what I understood, not much, except that its spike protein has many more mutations than the Delta variant […]
(E) The beautiful city of Manaus, full of history about the Amazonas, reached natural herd immunity in the Fall of 2020 when around 75% to 80% of its population had […]
(E) Eight French Polynesian patients in intensive care from Covid-19 were transported on Friday, September 17th on a plane from Tahiti to Paris in a 22 hours flight. The cost […]
(E) A few recent articles that summarize the present state of knowledge about the Delta variant from the revue Nature: Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization How […]
(T) An excellent article from Maxime Nauwynck on “how has AI contributed to dealing with the COVID-19 pandemic?” published in Stanford Gradient’s blog. The article looks at the contribution in […]
(E) Sanofi, the largest vaccine manufacturer in the world, and its partner GSK just announced the result of their vaccine that is based on an adjuvanted recombinant protein for their […]
(E) There are countries such as New Zealand and Taiwan, where political and health care officials do not tolerate any spread of the SARS-Cov-2 (note that the political leaders in […]
(E) Another remarkable blog article, “the CureVac Vaccine, and a brief tour through some of the wonders of nature“, from (software engineer) blogger Bert Hubert who also wrote last year […]
(E) A remarkable blog article, “exploring the Supply Chain of the Pfizer/BioNTech and Moderna COVID-19 vaccines“, from another (software engineer) blogger Jonas Neubert on discovering and understanding the supply chain […]
(E) I feel very privileged to not only have received my second Covid-19 vaccine dose today but also that my two doses were an mRNA vaccine, the one from Pfizer-BioNtech. […]
(E) A very interesting article on Professor Ron Davis, from the Stanford Genome Technology Center, trying to save his son from the long-term effects of myalgic encephalomyelitis — a disease […]
(T) A biotech company Adaptive Biotechnologies has developed a new test, called T-Detect Covid, that looks at signals of past Covid infections in the body T cells immune system. The […]
(E) We have now known for over a year the two companies that delivered the first two Covid-19 vaccines – BioNtech and Moderna, based on mRNA. What we are now […]
(T) In this third blog post about the applications of deep learning techniques to structural biology research, I will summarize a recent research study on virus mutation.The recent Covid-19 pandemic […]
(E) Moderna released today new data about the protection of its vaccine against the new SARS-Cov-2 variants: “Moderna COVID-19 Vaccine Variants Update“. Long story short, the Moderna vaccine provides the […]
(E) Today, Moderna announced the results of its phase 3 study, and gave some additional details about its vaccine. Moderna vaccine is slightly more efficient than the one from BioNTech, […]
(E) The second wave is here. Infections have been rising to the roof: Europe, the U.S., South America, and Russia. The U.S have now over 150,000 new daily cases, and […]
(E) Today is a good day! Pharmaceutical giant partner Pfizer announced today that the vaccine developed with its partner BioNTech, a bio-tech company located in Mainz in Germany, against the […]
(E) Taiwan and New Zealand have a huge advantage over other countries fighting the propagation of SARS-CoV-2: they are islands. Closing and reopening offices, schools, restaurants, gyms do not work. […]
(E) Looking back at the mistakes that caused human lives, Professor Philippe Parola, directeur de service de soins et d’unité de recherche à L’Institut Hospitalo-Universitaire (IHU) de Marseilles, looked back […]
(E) Excellent research from UCSF, Institut Pasteur, Gladstone Institutes, and Icahn School of Medicine at Mount Sinai to find the right antiviral drugs for Covid-19: “A SARS-CoV-2 protein interaction map […]
(E) Yale School of Medicine has updated its initial treatment algorithm for hospitalized patients with non–severe COVID-19 which uses hydroxychloroquine and tocilizumab: Yale Releases COVID-19 Treatment Algorithm Covid-19 adult treatment […]